As an adjunctive treatment, empagliflozin improves glycaemic control in patients with HNF1A-related maturity-onset diabetes ...
“Integrating these data in large samples allowed us to identify early metabolic pathway changes that precede type 2 diabetes, ...
By Dennis Thompson HealthDay ReporterWEDNESDAY, Jan. 21, 2026 (HealthDay News) — Even a brief round of Ozempic can help ...
A simple finger-prick blood test can find those at risk so they can get the right treatment.
Diabetes Canada is proud to announce the winners of its End Diabetes Awards, an annual competition that aims to improve the ...
Analyzing molecular changes in two types of peripheral nerves that are affected in diabetic peripheral neuropathy – the sural ...
Jan 20 (Reuters) - Danish drugmaker Novo Nordisk and Canada-based privately held Aspect Biosystems said on Tuesday they have ...
Pelayo was introduced to inhaled insulin by her endocrinologist, Dr. Nora Barsony. “It's a little tiny powder that goes right ...
UC Riverside led mouse study finds microplastics affect male and female offspring differently. Researchers at the, Riverside ...
Zacks Investment Research on MSN
NVO expands Aspect tie-up to advance curative diabetes cell therapies
Novo Nordisk NVO and Aspect Biosystems announced that they are advancing their partnership into a new phase focused on ...
A landmark UK study involving tens of thousands of families has shown that childhood screening for type 1 diabetes is ...
People whose biological mothers had diabetes during pregnancy are more likely to develop MS as adults, according to a study ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback